Evidence map›Paper›PMID 39509658›Full record

ReviewACS synthetic biology2024

Modulating Microbial Materials - Engineering Bacterial Cellulose with Synthetic Biology.

Koray Malcı, Ivy S Li, Natasha Kisseroudis, Tom Ellis

Abstract readReview
In one paragraph

Review in ACS synthetic biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Exploring Genome-Wide Mutation Dynamics and Bacterial Cellulose Impairment inComputational and structural biotechnology journal · 2026
    Article
  5. Genetic Impacts on the Structure and Mechanics of Cellulose Made by Bacteria.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Koray MalcıDepartment of Bioengineering, Imperial College London, London SW7 2AZ, U.K.
Ivy S LiDepartment of Bioengineering, Imperial College London, London SW7 2AZ, U.K.
Natasha KisseroudisImperial College Centre for Synthetic Biology, Imperial College London, London SW7 2AZ, U.K.
Tom EllisDepartment of Bioengineering, Imperial College London, London SW7 2AZ, U.K.ORCID 0000-0001-5392-976X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The fusion of synthetic biology and materials science offers exciting opportunities to produce sustainable materials that can perform programmed biological functions such as sensing and responding or enhance material properties through biological means. Bacterial cellulose (BC) is a unique material for this challenge due to its high-performance material properties and ease of production from culturable microbes. Research in the past decade has focused on expanding the benefits and applications of BC through many approaches. Here, we explore how the current landscape of BC-based biomaterials is being shaped by progress in synthetic biology. As well as discussing how it can aid production of more BC and BC with tailored material properties, we place special emphasis on the potential of using BC for engineered living materials (ELMs); materials of a biological nature designed to carry out specific tasks. We also explore the role of 3D bioprinting being used for BC-based ELMs and highlight specific opportunities that this can bring. As synthetic biology continues to advance, it will drive further innovation in BC-based materials and ELMs, enabling many new applications that can help address problems in the modern world, in both biomedicine and many other application fields.

Indexed as

BacteriaCelluloseSynthetic BiologyBiocompatible MaterialsBioprintingPrinting, Three-DimensionalBiocompatible MaterialsCellulose3D bioprintingbacterial cellulosebiomaterialengineered living materialsKomagataeibactersynthetic biology

Identifiers

PMID39509658
PMCPMC11669176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.